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OBJECTIVES: This study was designed to identify patient pre-
ferences for different aspects of Crohn’s disease (CD) mainte-
nance therapy for people with CD in Spain. METHODS: Main
attributes of CD maintenance treatment were determined from a
review of the literature and consultations with medical experts
and patients. The discrete choice experiment included 5
attributes: type of drug administration, disease control, mild-to-
moderate adverse events, serious adverse events and tumor inci-
dence, plus a cost attribute in order to estimate willingness to pay
(WTP) for improvements in attribute levels. A pilot study with 20
patients was carried forward to identify areas of misunderstand-
ing. Two hundred and eight patients with a diagnosis of CD
were presented with pairs of hypothetical treatment proﬁles with
varied levels of adverse events, disease control, type of adminis-
tration, tumor incidence and cost. Questions were also included
to collect socio-demographic data. Data were analyzed using a
random effects probit model. RESULTS: All attributes had the
expected polarity and all were signiﬁcant predictors of choice,
except for the mild-to-moderate adverse events attribute, that
was excluded from the analysis. Patients WTP were, €11,124/
month for a reduction of a 10% in the probability of presenting
a tumor, €227/month for a 10% reduction in the serious adverse
events; and €211/month for an increase of a 10 % in the prob-
ability of obtaining a clinical response. Patients were also willing
to pay €276/month and €223/month to have their treatment
administered orally rather than with an injection or an infusion
respectively. CONCLUSIONS: Spanish CD patients have well-
deﬁned preferences among maintenance treatment attributes and
are willing to accept tradeoffs among attributes. Participants
indicated that they are willing to accept elevated serious adverse
event risks but few risks of neoplasia in exchange for clinical
efﬁcacy. The perspective of the patients should be taken into
account when making treatment decisions.
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OBJECTIVES: This study was designed to capture patient pre-
ferences for different aspects of Crohn’s disease (CD) treatment
for people with CD in Spain. METHODS: Main attributes of CD
ﬂare-up treatment were determined from a review of the litera-
ture and consultations with medical experts and patients. The
discrete choice experiment (DCE) included 5 attributes: type of
drug administration, disease control, aesthetic effects, mild-to-
moderate adverse events and serious adverse events, plus a cost
attribute in order to estimate willingness to pay (WTP) for
improvements in attribute levels. A pilot study with 20 patients
was carried forward to identify areas of misunderstanding. One
hundred sixty-eight patients with a diagnosis of Crohn’s disease
were presented with pairs of hypothetical treatment proﬁles with
varied levels of adverse events, disease control, type of adminis-
tration and cost. Questions were also included to collect socio-
demographic data (including income). Data were analyzed using
a random effects probit model. RESULTS: All attributes had the
expected polarity and all were signiﬁcant predictors of choice,
i.e. participants showed a preference for less severe adverse
effects, greater ﬂare control and less cost. Patients were WTP
for a reduction of a 10% in the probability of experiencing:
serious adverse events, €1443.53/month; aesthetic adverse
events, €54.50/month and mild-to-moderate adverse events,
€3.86/month and €135.06/month for an increase of a 10% in the
probability of obtaining a clinical response. Patients were also
willing to pay €146.91/month and €228.66/month to have their
treatment administered orally rather than with an injection or an
infusion respectively. CONCLUSIONS: Patients with CD have
well-deﬁned preferences among treatment attributes and are
willing to accept tradeoffs among attributes. Study participants
indicated that they are willing to accept elevated mild-to-
moderate or aesthetic adverse event risks in exchange for clinical
efﬁcacy. The perspective of the patients should be taken into
account when making treatment decisions.
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OBJECTIVES: A recent Department of Health pharmacy white
paper emphasized the importance of public pharmacies and self
management of minor ailments. If self-care is an important
vehicle for the delivery of cost-effective care as the DH white
paper suggests, then there is a need to understand individuals’
health perceptions and treatment seeking behaviour for minor
ailments. To inform policy in this area we report the results of a
study of self diagnosis, treatment behaviour and public percep-
tion regarding common, minor bowel ailments. METHODS:
The survey evaluated female behaviour and attitudes towards
a variety of sensitive health issues, including constipation. A
sample of 2220 women aged >18 were recruited to participate in
an on-line survey. The sample was nationally represented by age,
social grade and geographical region. Summary statistics were
generated for individual survey items as well as disaggregated
responses stratiﬁed by age and region. RESULTS: Amongst par-
ticipants 42% reported suffering from constipation in the past
10 years. The three most common sources of information
sought regarding their condition included doctors 68%, internet
resources 48% and pharmacists 31%. Of those with constipation
only, 30% considered the condition to be embarrassing, with the
cause attributed to diet and lifestyle by 65% of those affected.
When suffering constipation, 53% suggested dietary modiﬁca-
tion would be their ﬁrst course of treatment and 40% suggested
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